BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+22.09%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$441M
AUM Growth
+$441M
(+38%)
Cap. Flow
+$45.7M
Cap. Flow
% of AUM
10.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Replimune Group
REPL
|
$45.7M |
Top Sells
| 1 |
InflaRx
IFRX
|
$39.5K |
Sector Composition
| 1 | Healthcare | 60.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $136M | 30.93% | 8,930,237 | – | – |
|
2
Solid Biosciences
SLDB
$427M
| $93.9M | 21.3% | 1,989,444 | – | – |
|
|
APTX
3
DELISTED
Aptinyx Inc. Common Stock
APTX
| $64.4M | 14.62% | 2,225,092 | – | – |
|
|
4
InflaRx
IFRX
$108M
| $60.6M | 13.75% | 1,764,888 -1,150 | -0.1% | -$39.5K |
|
|
5
Replimune Group
REPL
$422M
| $45.7M | 10.37% | +2,838,968 | New | +$45.7M |
|
|
MRNS
6
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $39.8M | 9.03% | 3,977,453 | – | – |
|